JOURNAL OF CANCER RESEARCH, TREATMENT & PREVENTION
Journal Status
| Acceptance Rate | 70 % |
| Submission to final decision | 30 days |
| Acceptance to publication | 15 days |
| Cite Score | 1.00 |
Journal of Cancer Research, Treatment & Prevention is a peer-reviewed open access publication. It is published annually. Abbreviated title is J Cancer Res Treat & Prev. It accepts manuscripts relevant to experimental and clinical cancer research. Subjects include carcinogenesis, tumor biology, molecular oncology, cancer genetics, tumor immunology, epidemiology, predictive markers and cancer prevention, pathology, cancer diagnosis, screening and therapies including chemotherapy, surgery, radiation therapy, immunotherapy, gene therapy, multimodality treatment and palliative care.
Editor, Koeffler, H. Phillip is a Professor of Medicine at UCLA School of Medicine and holder of the Mark Goodson Chair in Oncology Research at Cedars-Sinai Medical Center. He is a specialist in Medicine, Hematology and Oncology. He has 44 years of experience in Medicine, Hematology and Oncology. He has published more than 800 peer-reviewed scientific articles and book chapters with overall 80197 citations.
We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field or provide a venue for a deeper investigation into an existing research area.
Latest Articles
Recurrent Para-testicular Rhabdomyosarcoma: A Case Report
Abdul Haseeb1*, Sana Hamayun2, Wagma Hidayat2, Hamza Rafi2 and Haq Nawaz2
Department of General Surgery, Hayatabad medical complex, Peshawar, Pakistan
*Corresponding Author: Abdul Haseeb, Department of Urology, Institute of kidney diseases, Hayatabad medical complex, Peshawar, Pakistan.
Exploring the Value of Sequential Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: Insights from a Single Institution's Retrospective Analysis
Ben Walters1, Rajanee Bhana2, Shahul Khan2, Apurna Jegannathen2, Abdelfattah Elmasry3 and Selvaraj Giridharan4*
1Rotherham Hospital, UK
2Royal Stoke University Hospitals, UK
3Derby Hospitals, UK
4MBBS, MSc, FRCP, FRCR, Department of Medical Oncology, Tawam Hospitals, Al Ain, UAE
*Corresponding Author: Selvaraj Giridharan, Department of Medical Oncology, Tawam Hospitals, Al Ain, UAE.
Ficus benjamina as a Candidate for Cancer Therapy Due to its Selective Toxicity Property
Faith Ayobamidele Obafemi* and Grace Umahi-Ottah
Department of Physiology, Faculty of Basic Medical Sciences, Ebonyi State University, Abakaliki, Nigeria
*Corresponding Author: Faith Ayobamidele Obafemi, Department of Physiology, Faculty of Basic Medical Sciences, Ebonyi State University, Abakaliki, Nigeria.
A Review of Global Cancer Prevalence and Therapy
Faith Ayobamidele Obafemi* and Grace Umahi-Ottah
Department of Physiology, Faculty of Basic Medical Sciences, Ebonyi State University, Abakaliki, Nigeria
*Corresponding Author: Faith Ayobamidele Obafemi, Department of Physiology, Faculty of Basic Medical Sciences, Ebonyi State University, Abakaliki, Nigeria.
Pharmacoeconomics and Cancer: Medical Issue of Economists or Governments?
Adrian Hunis*
School of Medicine, University of Buenos Aires, Maimonides University, Argentina
*Corresponding Author: Adrian P Hunis, School of Medicine, University of Buenos Aires, Maimonides University, Argentina.
High-grade Spindle Cell Squamous Carcinoma of the Supraglottic Larynx Treated with Definitive Curative Radiation Therapy- A Rare Case Report
Yashaswini Shivashankara1, Naemieh Mohammad Kamel Aljasem2, Trilok Kiribagha Chandrashekara3* and Cherian Tampy4
1Specialist Radiation Oncologist, Gulf International Cancer Center, Abu Dhabi, UAE
2Specialist Pathologist, NMC Royale Hospital, Abu Dhabi, UAE
3Specialist Anesthesiologist, Mediclinic Airport Road Hospital, Abu Dhabi, UAE
4Consultant Medical Oncologist, NMC Specialty Hospital, Abu Dhabi, UAE
*Corresponding Author: Trilok Kiribagha Chandrashekara, Specialist Anesthesiologist, Mediclinic Airport Road Hospital, Abu Dhabi, UAE.
Prognostic Value of Lymphocyte-to-Monocyte Ratio and Neutrophil-to-Lymphocyte Ratio in Patients with Colorectal Cancer: "A Retrospective Cohort Study"
Elkhazin Sana1*, Thampy Cherian2, Osman Mohammad3 and Diab Mohanad1
1Burjeel VPS Hospital, UAE
2NMC speciality hospital, Abu Dhabi, UAE
3SEHA, SKMC Hospital, Abu Dhabi, UAE
*Corresponding Author: Sana Elkhazin, Burjeel VPS Hospital UAE.
Childhood Cancer Survivors Follow-up: A study from a Third-Level Hospital in a Low-Middle Income Country
Vega Espinoza Sheila1*, Sanchez Zubieta Fernando2 and Romo Rubio Hugo2
1Department of Pediatric Oncology/Hematology, Hospital Regional “Dr. Valentin Gomez Farías”, ISSSTE, Guadalajara, México
2Department of Pediatric Oncology/Hematology, Hospital Civil de Guadalajara “Dr. Juan I. Menchaca”, Guadalajara, México
*Corresponding Author: Vega Espinoza Sheila, Department of Pediatric Oncology/Hematology, Hospital Regional “Dr. Valentin Gomez Farías”, ISSSTE, Guadalajara, México.